Abstract
Primary biliary cirrhosis (PBC) is an autoimmune disease in which intrahepatic bile ducts are targeted by an immune-mediated injury. This disease tends to progress to fibrosis and cirrhosis with hepatic failure. The authors report a case of a 50-year-old rheumatoid arthritis (RA) patient, with erosions and seropositive for rheumatoid factor and anti-citrullinated peptide antibodies, with 18 years disease duration refractory to prednisolone and several disease-modifying antirheumatic drugs, either conventional or biological (adalimumab and etanercept). In April 2007, she started therapy with rituximab (RTX) with good European League Against Rheumatism response achieved 9 months later. In June 2008, she was admitted with intrahepatic cholestasis, steatorrhea, and spontaneous fractures of various ribs. After excluding cholelitiasis, as well as infectious and neoplastic diseases a liver biopsy was performed that was compatible with the diagnosis of PBC. The antinuclear antibodies (1/160) were positive as well as the antimitochondrial antibodies (1/640). Other antibodies were negative such as anti-SSA and anti-SSB. Afterwards, the patient started ursodesoxycholic acid 15 mg kg-1 day-1 with progressive improvement of cholestatic markers. A labial salivary gland biopsy was performed and showed findings compatible with the concomitant diagnosis of Sjögren’s syndrome. Based on this clinical report, a detailed review of the clinical aspects of PBC is presented as well as its association with other immune-mediated inflammatory diseases, particularly, with RA.
Similar content being viewed by others
References
Kaplan MM (2005) Primary biliary cirrhosis. N Engl J Med 353:1261
Nguyen DL, Juran BD, Lazaridis KN (2010) Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 24(5):647–654
Selmi, C, Gershwin E (2008) Primary biliary cirrhosis. Diagnostic criteria in autoimmune diseases, vol. 55. Humana Press, pp 291–294
Inoue K, Hirohara J, Nakano T et al (1995) Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 15:70–77
Leuschner U (2003) Primary biliary cirrhosis—presentation and diagnosis. Clin Liver Dis 7:741–758
Poupon RE, Lindor KD, Cauch-Dudek K et al (1997) Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastrenterology 90:247–249
Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42(5):1194–1202
Culp KS, Fleming CR, Duffy J et al (1982) Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 57:365–370
Uddenfeldt P, Danielsson A, Forssell A et al (1991) Features of Sjögren’s syndrome in patients with primary biliary cirrhosis. J Intern Med 230:443–448
Siegel JL, Luthra H, Donlinger J, Angulo P, Lindor K (2003) Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol 9:340–343
Elta GH, Sepersky RA, Goldberg MJ et al (1983) Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 28:971–975
Child DL, Mathews JA, Thompson RP (1977) Arthritis and primary biliary cirrhosis. Br Med J 2(6086):557
Mills P, MacSween RN, Watkinson G (1977) Arthritis and primary biliary cirrhosis. Br Med J 2(6096):1224
Walker NJ, Zurier RB (2002) Liver abnormalities in rheumatic diseases. Clin Liver Dis 6(4):933–946
Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129
Spooner RJ, Smith DH, Bedford D, Beck PR (1982) Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol 35(6):638–641
Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, Irisawa A, Ohira H (2010) Clinical features of liver dysfunction in collagen diseases. Hepatol Res 40(11):1092–1097
Watt FE, James OF, Jones DE (2004) Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population based cohort study. QJM 97:397–406
Caramella C, Avouac J, Philippe S et al (2007) Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 74:279–281
Marasi IB, Gagetta M, Rossi V et al (2001) Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 60:1046–1049
Ely GM, Perruquet JL, Newman ED (1996) The arthritis of primary biliary cirrhosis: clinical features and associated immune processes. J Clin Rheumatol 2(4):191–196
Mills PR, Vallance R, Birnie G et al (1981) A prospective survey of radiological bone and joint changes in primary biliary cirrhosis. Clin Radiol 32(3):297–302
Clarke AK, Galbraith RM, Hamilton EB, Williams R (1978) Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 37(1):42–47
Takagi T, Kasukawa R (1994) Association of autoimmune disease in primary biliary cirrhosis. Nippon Rinsho 52(1):251–255
Uddenfeldt P, Danielsson A (1986) Evaluation of rheumatic disorders in patients with primary biliary cirrhosis. Ann Clin Res 18(3):148–153
Teufel A, Weinmann A, Kahaly GJ et al (2010) Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 44(3):208–213
Datta A, Deodhar SD, Datta U et al (1990) Non-organ specific and organ specific antibodies in rheumatoid arthritis. Indian J Med Res 92:228–232
Zurgil N, Bakimer R, Moutsopoulos HM et al (1992) Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. J Clin Immunol 12(3):201–209
Mouritsen S, Demant E, Permin H, Wiik A (1986) High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases. Clin Exp Immunol 66(1):68–76
Koga T, Migita K, Miyashita T et al (2008) Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases. Clin Exp Rheumatol 26(1):121–124
Santiago M, Baron M, Miyachi K et al (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27(1):77–83
Walker EJ, Hirschfield GM, Xu C et al (2009) CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum 60(4):931–937
Meyers RP, Shaheen AA, Swain MG et al (2007) Rituximab for primary biliary cirrhosis (PBC) refractory to ursodeoxycholic acid (UDCA). Hepatology 46(Suppl 1):550A
Kawano A, Shimoda S, Kamihira T, Ishikawa F, Niiro H, Soejima Y, Taketomi A, Maehara Y, Nakamura M, Komori A, Migita K, Ishibashi H, Azuma M, Gershwin ME, Harada M (2007) Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J Immunol 179(5):3315–3324
Acknowledgments
The authors thank Dr. Ana Afonso and Dr. Maria Adelaide Milheiro from the Pathology Department of Hospital Curry Cabral, Lisbon, for the clinical discussion and for sharing the pathology images.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Polido-Pereira, J., Rodrigues, A.M., Canhão, H. et al. Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review. Clin Rheumatol 31, 385–389 (2012). https://doi.org/10.1007/s10067-011-1879-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1879-y